Key Takeaways:  

• National Institute of Child Health and Human Development awards $2.8 million to the University of Houston to lead the first clinical trial evaluating the remotely delivered PALS parenting program to support healthy brain development in infants born preterm.  

• Researchers will examine whether online support after NICU discharge strengthens brain development linked to emotional and mental health.  

• Research advances UH Health’s mission to improve lifelong health through interdisciplinary research and innovative care. 

HOUSTON, July 29, 2026 — A University of Houston psychologist has received a $2.8 million grant from the National Institute of Child Health and Human Development to lead the first randomized clinical trial testing whether a remotely delivered parenting program can improve healthy infant brain development to support long-term mental health outcomes for babies born prematurely.  

Researchers will examine whether providing parents with web-based support during the critical weeks and months after premature infants leave the hospital strengthens early brain development linked to emotional and mental health. 

In the United States, more than one in 10 babies are born prematurely each year and the rate of mental health disorders among youth and adults born preterm is rising, posing substantial burden to individuals, families and society. Texas has some of the highest rates of preterm birth in the country.  

While advances in neonatal medicine have dramatically improved survival rates, babies born prematurely remain at greater risk for developmental and mental health disorders.  

The scalable intervention could transform how families receive support after discharge from the neonatal intensive care unit, bringing evidence-based support into the home. The research aligns with UH Health’s mission to advance innovative, accessible solutions that improve health outcomes and reduce disparities for vulnerable populations. 

Johanna Bick, associate professor of psychology and director of the Laboratory of Early Experience and Development at UH, will lead the trial of a remotely delivered version of Play and Learning Strategies (PALS), a parenting program that has been adapted for parents of prematurely born infants. PALS is an evidence-based parenting intervention program designed to strengthen parent-child bonds and stimulate early cognitive, language and social-emotional development. 

“The field is beginning to understand how preterm birth can alter the development of neural circuits that underlie long-term mental health,” said Bick. “This study will allow us to test whether increased support during one of the most sensitive periods of brain development can help place infants on a more typical developmental trajectory.” 

Many effective parenting programs end when babies leave the NICU, missing a critical period when parents need support most and babies’ brains are developing rapidly. Because the program is delivered online, it has the potential to reach families regardless of where they live while engaging multiple caregivers during this critical period. 

Parents or caretakers of prematurely born infants will be randomly assigned to either the remotely delivered PALS program or a comparison program. Researchers will evaluate how the intervention affects parental responsiveness, infant social and emotional development, emotion regulation and brain development using behavioral assessments and advanced neuroimaging and neurophysiological measures. 

Preterm birth, defined as delivery before 37 weeks of gestation, remains a leading cause of neurodevelopmental impairments, including motor dysfunction, cognitive delays, and behavioral issues. The immature brain in these infants is particularly sensitive to extrinsic stimuli and environmental factors, which makes early intervention crucial. The newly developed GMT approach, rooted in the analysis and facilitation of spontaneous general movements, targets fundamental neural circuits during a critical window of postnatal brain plasticity. It leverages the intrinsic motor patterns that naturally emerge in infants to foster more adaptive neurodevelopment.

The methodology of the study was meticulously designed as a randomized clinical trial, enrolling a cohort of preterm infants admitted to neonatal intensive care units (NICUs). The intervention group underwent a structured GMT regimen, which involved daily sessions where trained therapists facilitated and encouraged infants’ spontaneous general movements. These maneuvers were not arbitrary but based on well-established frameworks characterizing normal versus pathological general movements, which are predictive markers of later neurological impairments such as cerebral palsy. The control group received standard care without additional GMT sessions.

Detailed neurodevelopmental assessments were conducted at multiple stages from infancy through early childhood to capture both short-term and long-term outcomes. The primary focus was on motor skill acquisition, cognitive development, and neurobehavioral profiles. To quantify the therapeutic impact, the team employed advanced neuroimaging techniques, including diffusion tensor imaging (DTI) and structural magnetic resonance imaging (MRI), alongside standardized developmental scales such as the Bayley Scales of Infant Development.

Remarkably, infants who received GMT exhibited significantly enhanced motor milestones compared to controls, displaying more fluid and coordinated spontaneous movements early in life. This translated into measurable improvements in fine and gross motor skills by the age of two years. Neuroimaging revealed increased myelination and improved integrity of corticospinal tracts, suggesting that GMT may promote more robust neuroplasticity and neural network connectivity. The study also noted enhancements in cognitive domains and reduced signs of neurobehavioral disturbances, signaling a holistic benefit beyond motor function.

The underlying neurophysiological mechanisms proposed involve the stimulation of endogenous central pattern generators (CPGs) located within the spinal cord and brainstem, which govern rhythmic movement patterns. Through repetitive activation and modulation of these circuits via GMT, the developing nervous system undergoes adaptive reorganization, possibly preventing the maladaptive pruning that often occurs in preterm infants. The researchers speculate that this shaping of neural pathways in the earliest stages sets a foundation for more sophisticated motor and cognitive capacities later in life.

Intriguingly, this research aligns with and expands upon previous observational studies emphasizing the prognostic value of general movement assessments (GMA). For years, clinicians have used GMA as a non-invasive tool to predict neurodevelopmental outcomes, but the transition from passive observation to active therapeutic intervention represents a paradigm shift. By harnessing naturalistic movement patterns as a therapeutic vehicle, GMT embodies a biomimetic strategy that respects and amplifies intrinsic developmental processes.

From a clinical implementation perspective, GMT is appealing because it is non-invasive, cost-effective, and easily integrated into existing NICU routines without requiring sophisticated equipment. The training protocol for therapists emphasizes attunement to subtle infant cues and fostering movement variability, both of which are critical for maximizing neuroplastic potential. Moreover, parental involvement was encouraged, with caregivers taught similar techniques to continue therapy post-discharge, thereby extending the intervention’s reach during critical out-of-hospital developmental windows.

The study also rigorously addressed potential confounders by stratifying infants based on gestational age, birth weight, and comorbidities, ensuring the observed effects were attributable to GMT rather than extraneous factors. The randomized design and longitudinal follow-up bolster the validity and reproducibility of the findings. While the study acknowledges limitations such as sample size and heterogeneity of the preterm infant population, it sets a robust foundation for multicenter trials and international collaborative efforts.

Looking ahead, the translational potential of GMT opens exciting research avenues. Integrating this therapy with adjunctive modalities, such as neuromodulation or pharmacotherapy targeting neurodevelopment, could potentiate outcomes even further. Additionally, machine learning algorithms analyzing infant movement patterns in real-time could optimize therapy personalization, delivering adaptive, precision-based interventions tailored to each infant’s unique neurodevelopmental profile.

Perhaps most profoundly, GMT’s success challenges traditional notions that early motor impairments are static or irreversible. Instead, it underscores the remarkable plasticity of the infant brain and the vital role of appropriately timed, targeted interventions to recalibrate developmental trajectories. This paradigm advocates for a proactive, preventative approach rather than reactive treatment, reframing neurodevelopmental care in neonatal medicine.

The global burden of preterm birth-related neurodevelopmental disabilities is immense, impacting millions of families and healthcare systems worldwide. Interventions such as GMT could dramatically reduce long-term morbidity, diminish the need for intensive rehabilitative services, and improve quality of life for countless children. Furthermore, policy implications include advocating for routine neurodevelopmental screening and early therapeutic programs embedded within neonatal care standards.

Beyond the clinical and scientific spheres, this study resonates with broader societal values—promoting equitable healthcare access, empowering parents with actionable tools, and fostering the well-being of the most fragile among us. It exemplifies how meticulous research can translate into tangible benefits, bridging the gap between fundamental neuroscience and everyday clinical practice.

In conclusion, Badura and colleagues have delivered a landmark contribution to neonatal medicine by demonstrating that general movement-based therapy holds transformative potential for supporting neurodevelopment in preterm infants. This randomized clinical trial not only confirms the predictive power of spontaneous movement patterns but pioneers their active use in therapy to shape healthier developmental outcomes. The integration of GMT into standard care protocols promises to usher in a new era of personalized, early-life interventions grounded in the intrinsic dynamics of infant neurobiology.

As the medical community embraces these findings, ongoing research and clinical adoption will be crucial to refine protocols, validate long-term benefits, and expand access worldwide. The hope is clear: with timely and targeted intervention, we can rewrite the neurodevelopmental destinies of preterm infants, offering them a more robust start and a brighter future.

Subject of Research: Neurodevelopmental therapy in preterm infants using general movement-based interventions.

Article Title: General movement based therapy to support neurodevelopment of preterm infants: a randomized clinical trial.

Article References:
Badura, A., Dietz, A., Zeman, F. et al. General movement based therapy to support neurodevelopment of preterm infants: a randomized clinical trial. Pediatr Res (2026). https://doi.org/10.1038/s41390-025-04734-2

Image Credits: AI Generated

DOI: 10.1038/s41390-025-04734-2

Adverse childhood experiences encompass a spectrum of traumatic events such as abuse, neglect, and household dysfunction, factors well-documented to shape psychological, behavioral, and physiological outcomes across the lifespan. The emerging concept of screening neonates for ACEs acknowledges that prenatal stressors and maternal exposure to adversity can have cascading effects on neonatal health outcomes, including neurodevelopmental, immunological, and metabolic disruptions. These findings underscore the necessity of early identification within NICU settings, where premature and critically ill infants could most benefit from targeted preventive strategies.

The study was launched in a Level III NICU, indicating the highest level of neonatal care available, equipped to handle extremely preterm and critically ill newborns. This environment presents both a unique challenge and an opportunity for ACEs screening due to the vulnerability and complexity of conditions treated. Implementing a quality improvement initiative (QI) to heighten screening rates demanded meticulous integration of comprehensive ACEs assessments into routine neonatal care workflows without disrupting clinical operations or compromising patient safety.

Central to the study’s methodology was the deployment of a structured, multidisciplinary approach involving neonatologists, nurses, social workers, and quality improvement specialists. The team devised protocols to systematically document maternal histories and environmental stressors potentially influencing neonatal well-being. This collaborative framework functioned not only to collect data but also to sensitize clinical staff to the nuances of ACEs, fostering a culture of trauma-informed care within the NICU environment.

One of the primary technical hurdles highlighted by the researchers was balancing the depth of screening with time constraints and parental consent considerations. Given the delicate ICU atmosphere, the team innovated by creating streamlined screening tools to quickly yet thoroughly evaluate risk factors. These tools accounted for maternal psychosocial factors, familial dynamics, and prenatal exposures known to correlate with perinatal adversity, thereby maximizing the yield of relevant information while respecting ethical boundaries.

A significant portion of the study scrutinized the implications of previously underrecognized ACEs, such as prenatal maternal stress related to socioeconomic instability, domestic violence, and mental health disorders. By expanding the definition of ACEs beyond traditional childhood events, the investigation broadened the scope of neonatal risk assessment. This comprehensive lens revealed a higher prevalence of adversity-related markers than previously documented, emphasizing the latent vulnerabilities in this patient cohort.

The researchers also elucidated neurobiological mechanisms by which prenatal exposure to adversity might affect neonates. Chronic maternal stress can induce dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to elevated cortisol levels and inflammatory cytokines transferred to the fetus. Such physiological alterations can impair brain development, immune function, and metabolic pathways, setting the stage for lifelong vulnerabilities and diseases. Recognizing these pathways underscores the transformative potential of early ACE screening as a gateway to timely therapeutic interventions.

Crucially, the study’s quality improvement initiative adopted Plan-Do-Study-Act (PDSA) cycles, an iterative process tailored to refine clinical practice through data-driven feedback. Initial cycles involved pilot testing the ACE screening protocol, gathering frontline healthcare professionals’ input, and analyzing barriers to implementation. Subsequent refinements enhanced tool usability and integrated electronic health record (EHR) prompts, facilitating consistency and compliance among care teams.

The impact of these interventions was striking. Within a relatively short period, the NICU succeeded in raising ACE screening coverage to 50%, a twenty-five-fold increase from the baseline rate. This achievement not only underscores the feasibility of integrating ACE assessments into acute care settings but also provides a replicable model for other NICUs aiming to embed trauma-informed care systematically.

Beyond quantitative improvements, the initiative fostered qualitative advancements in caregiver-family communication. Enhanced awareness of ACEs among NICU staff translated into more empathetic dialogues with parents, addressing concerns about external stressors and promoting holistic care strategies. Such shifts reinforce the importance of psychosocial dimensions in neonatal management, bridging the gap between biomedical and social determinants of health.

The study’s findings also invite broader reflections on public health and policy. Screening neonates for ACEs introduces a paradigm where primary prevention can commence at the earliest stages of life, potentially mitigating the ripple effects of adversity across generations. By identifying at-risk infants promptly, health systems can orchestrate early multidisciplinary interventions that encompass medical, psychological, and social support services, fostering resilience from the outset.

Given the complexities inherent in ACE screening, the researchers caution that further investigation is required to optimize screening instruments, ensure cultural sensitivity, and evaluate long-term outcomes of early identification. Nevertheless, their success in the NICU setting paves the way for integrated care models prioritizing trauma-informed practices across perinatal and pediatric medicine, marking a critical juncture in neonatal health paradigms.

In summary, this pioneering quality improvement initiative transcends traditional boundaries of ACEs research by targeting the neonatal period, an often-overlooked window of vulnerability. Its innovative implementation strategies, profound clinical insights, and potential to revolutionize early childhood health promotion hold immense promise. As neonatal care continues to evolve, embedding comprehensive ACE screening protocols could redefine preventive pediatrics and transform life trajectories for the most fragile patients.

Subject of Research: The study investigates the implementation and impact of screening for Adverse Childhood Experiences (ACEs) in neonates within a Level III Neonatal Intensive Care Unit, focusing on increasing screening rates to improve early identification and intervention.

Article Title: Improving Neonatal Adverse Childhood Experiences (ACEs) Screening in the NICU: A Quality Improvement Initiative

Article References:
Sacotte, K., Nampijja, J. & Torr, C. Improving Neonatal Adverse Childhood Experiences (ACEs) Screening in the NICU: A Quality Improvement Initiative. J Perinatol (2025). https://doi.org/10.1038/s41372-025-02498-5

Image Credits: AI Generated

DOI: 10.1038/s41372-025-02498-5

Keywords: Adverse Childhood Experiences, Neonatal Intensive Care Unit, Screening, Quality Improvement, Prenatal Stress, Trauma-Informed Care, Neonatal Health, Maternal Stress, Neurodevelopment